CD24 and neoplasm: This synergy between the Hippo-YAP pathway and CD24 not only underscores the complexity of tumor-immune interactions but also opens new avenues for therapeutic interventions aimed at disrupting these oncogenic signaling cascades to restore immune system competency in targeting malignancies.